The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology Consortium
Abstract Background Patient and Public Involvement (PPI) in clinical trial research is recognised as relevant but the active involvement of patients and the public in basic science or laboratory-based research is seen as more challenging and not often reported. PPI within the UK Coronavirus Immunolo...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | Research Involvement and Engagement |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40900-023-00446-1 |
_version_ | 1797817694254268416 |
---|---|
author | Erika Neves Aquino Paul Moss Mo Hafeez Robert Jasper Tony Kelly Lynn Laidlaw Vivienne Wilkes |
author_facet | Erika Neves Aquino Paul Moss Mo Hafeez Robert Jasper Tony Kelly Lynn Laidlaw Vivienne Wilkes |
author_sort | Erika Neves Aquino |
collection | DOAJ |
description | Abstract Background Patient and Public Involvement (PPI) in clinical trial research is recognised as relevant but the active involvement of patients and the public in basic science or laboratory-based research is seen as more challenging and not often reported. PPI within the UK Coronavirus Immunology Consortium (UK-CIC), a translational research project aimed at tackling some of the key questions about the immune system’s response to SARS-CoV-2, is an example of overcoming negative perceptions and obstacles. Given the widespread impact of COVID-19, it was important to consider the impact of UK-CIC research on patients and the public throughout, and the PPI panel were an integral part of the consortium. Findings Building in funding for a PPI panel to value involvement and ensuring effective expert administrative support and management of PPI were crucial to success. Facilitating relationships and quality interactions between public contributors and researchers required time and commitment to the project from all parties. Through creating a platform and open space to explore diverse views and a wide range of perspectives, PPI was able to influence researchers’ ways of thinking about their research and impact future research questions about COVID-19 immunology. Moreover, there was long-term impact from the involvement of the PPI panel in COVID-19 research and their value was reflected in invitations to contribute to additional immunology projects. Conclusion The ability to conduct meaningful PPI with basic immunology research has been shown possible through the UK-CIC in the context of the fast-moving COVID-19 pandemic. The UK-CIC project has laid the foundations for PPI in immunology and this should now be built upon for the advantage of future basic scientific research; PPI can impact greatly on laboratory-based research when given the opportunity to do so. |
first_indexed | 2024-03-13T08:57:13Z |
format | Article |
id | doaj.art-3ebf1a8182ea458aa57c988980d0cbfd |
institution | Directory Open Access Journal |
issn | 2056-7529 |
language | English |
last_indexed | 2024-03-13T08:57:13Z |
publishDate | 2023-05-01 |
publisher | BMC |
record_format | Article |
series | Research Involvement and Engagement |
spelling | doaj.art-3ebf1a8182ea458aa57c988980d0cbfd2023-05-28T11:30:49ZengBMCResearch Involvement and Engagement2056-75292023-05-019111310.1186/s40900-023-00446-1The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology ConsortiumErika Neves Aquino0Paul Moss1Mo HafeezRobert JasperTony KellyLynn LaidlawVivienne WilkesBritish Society for ImmunologyInstitute of Immunology and Immunotherapy, University of BirminghamAbstract Background Patient and Public Involvement (PPI) in clinical trial research is recognised as relevant but the active involvement of patients and the public in basic science or laboratory-based research is seen as more challenging and not often reported. PPI within the UK Coronavirus Immunology Consortium (UK-CIC), a translational research project aimed at tackling some of the key questions about the immune system’s response to SARS-CoV-2, is an example of overcoming negative perceptions and obstacles. Given the widespread impact of COVID-19, it was important to consider the impact of UK-CIC research on patients and the public throughout, and the PPI panel were an integral part of the consortium. Findings Building in funding for a PPI panel to value involvement and ensuring effective expert administrative support and management of PPI were crucial to success. Facilitating relationships and quality interactions between public contributors and researchers required time and commitment to the project from all parties. Through creating a platform and open space to explore diverse views and a wide range of perspectives, PPI was able to influence researchers’ ways of thinking about their research and impact future research questions about COVID-19 immunology. Moreover, there was long-term impact from the involvement of the PPI panel in COVID-19 research and their value was reflected in invitations to contribute to additional immunology projects. Conclusion The ability to conduct meaningful PPI with basic immunology research has been shown possible through the UK-CIC in the context of the fast-moving COVID-19 pandemic. The UK-CIC project has laid the foundations for PPI in immunology and this should now be built upon for the advantage of future basic scientific research; PPI can impact greatly on laboratory-based research when given the opportunity to do so.https://doi.org/10.1186/s40900-023-00446-1ImmunologyCOVID-19PPIPatient and public involvementPublic contributorsBasic science |
spellingShingle | Erika Neves Aquino Paul Moss Mo Hafeez Robert Jasper Tony Kelly Lynn Laidlaw Vivienne Wilkes The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology Consortium Research Involvement and Engagement Immunology COVID-19 PPI Patient and public involvement Public contributors Basic science |
title | The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology Consortium |
title_full | The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology Consortium |
title_fullStr | The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology Consortium |
title_full_unstemmed | The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology Consortium |
title_short | The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology Consortium |
title_sort | impact of patient and public involvement on covid 19 immunology research experiences from the uk coronavirus immunology consortium |
topic | Immunology COVID-19 PPI Patient and public involvement Public contributors Basic science |
url | https://doi.org/10.1186/s40900-023-00446-1 |
work_keys_str_mv | AT erikanevesaquino theimpactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium AT paulmoss theimpactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium AT mohafeez theimpactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium AT robertjasper theimpactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium AT tonykelly theimpactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium AT lynnlaidlaw theimpactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium AT viviennewilkes theimpactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium AT erikanevesaquino impactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium AT paulmoss impactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium AT mohafeez impactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium AT robertjasper impactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium AT tonykelly impactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium AT lynnlaidlaw impactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium AT viviennewilkes impactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium |